So researchers looked at 100 people who’d recovered from SARSCoV2 and found strong T-cell responses 6 months later - a sign of lasting immunity.

Then they looked to see if spike proteins (the ones the vaccines create) drove the response. You’ll never believe what happened next! pic.twitter.com/gt58ujpZur

— Alex Berenson (@AlexBerenson) May 1, 2021